[FREE SLIDE DECK] Key Players in Genetic Testing
We give an overview of the four genetic testing companies – 23andMe, Ancestry, Color, and Invitae – that are racing to the forefront of healthcare.
One giant question is swirling around the IPO of hot health insurer Oscar: Can the startup ever make money?
Oscar has been bleeding money since its start. Investing in Medicare Advantage and selling its tech may be its best bet at reaching profitability.
The data is in: COVID-19 vaccines are proving crucial in curbing the pandemic by slashing infections, hospitalizations, and deaths
The first real-world data shows coronavirus vaccines can help us forge a path out of the pandemic.
Johnson & Johnson's CEO doesn't want to go back to 'business as usual' after the pandemic and hopes public-private partnerships among pharmaceutical firms continue
"I hope we don't go back to doing business as usual," Johnson & Johnson CEO Alex Gorsky said in an interview with the Washington Post.
Oscar Health, the original buzzy health-insurance startup, fell 11% in its IPO. We pored over its 215-page filing to find 4 key takeaways.
In its S-1 filing, Oscar Health laid out its financials, its risks, and its dual-class stock structure.
Biden is picking up the work on cancer he started as Obama's VP. His science advisor nominee Eric Lander is expected to lead the effort.
A meeting with lawmakers Wednesday was expected to start the efforts by Biden, whose son died of brain cancer in 2015, to boost the search for a cure.
With J&J's vaccine, the US will have enough coronavirus shots for every adult in May, Biden says. Here's your vaccination timeline.
The US could distribute 500 million doses by the end of May — enough to vaccinate all of its adult population.
Telehealth Startups to Watch
Download this FREE report where Insider Intelligence details five companies working to address consumers' growing virtual care needs.
We got an exclusive look at the presentation that convinced Tiger Global and Humana to invest in a startup's bold vision to do hospitalizations at home at a $1.7 billion valuation
DispatchHealth raised $200 million from Tiger Global and other top investors with a presentation obtained by Insider.
A magic mushroom firm backed by Peter Thiel is now worth $2 billion and reportedly eyeing an IPO
Atai Life Sciences recently raised $157 million in its Series D funding round, and reports say its looking at a possible public listing.
Fast-food workers in LA face unmasked customers and unsafe workplaces, and are punished for speaking up about COVID-19, a damning new report says
Some fast-food restaurants in Los Angeles County failed to follow COVID-19 protocols and kept infections a secret, according to a new report.
Teachers and school staff should be vaccinated with at least one COVID-19 shot by month's end, President Joe Biden says
Biden told states to treat in-person learning as an essential service, which means prioritizing the vaccination of educators regardless of age.
Meet the top 14 psychedelics startups raising the most cash to develop new ways of treating depression, addiction, and more
Insider identified the psychedelics companies that raised the most funding in 2020. Atai, at the top of our list, raised $125 million in November.
Avatar robots are beginning to stake out their place in the workforce, and Japan is leading the way
Kentaro Yoshifuji of OryLab is one of a number of entrepreneurs experimenting in the avatar robot field
The US should have enough vaccines for every adult by May
These are Insider's biggest healthcare stories for March 3.
We've been wrong about how insulin has to be stored, and a new approach could revolutionize diabetes treatment for millions of people
For diabetics who lack electricity at home, a shift in how insulin is handled could be game-changing.
Texas isn't the only state lifting COVID-19 restrictions. Here's how 11 other states and cities are easing lockdowns, despite the CDC insisting that 'now is not the time.'
As Texas ended its mask mandate, Mississippi, Louisiana, and Michigan — as well as Chicago and San Francisco — all eased some COVID-19 restrictions.
The psychologist who helped D.C. police put words to their trauma after the Capitol attack has a model for other departments
Beverly Anderson has been working with D.C. police for decades as an independent psychologist. Since Jan. 6, she's been treating officers for trauma.
A top biotech VC and a top tech VC are making a $500 million bet in 2 of the hottest areas of healthcare
Biotech investor Arch Venture Partners and tech investor General Catalyst have teamed up on a SPAC focused on mental health and/or virtual health.
The biggest private psychedelics company in the world just raised a record $157 million, pushing psychedelics further into the mainstream
CEO Florian Brand told Insider that the money will be used to "double down" on the company's existing strategy.
Target, Macy's, Kroger, and more say they will still require masks, despite Texas and other states rolling back COVID-19 restrictions
Major retail stores Macy's and Target are sticking to federal advice and requiring all customers and employees to wear masks in Texas stores.
AstraZeneca earned more than $1 billion after selling its stake in Moderna
AstraZeneca sold its 7.7% stake in vaccine producer Moderna for around $1 billion last year, a "large proportion" of its 2020 equity portfolio sales.
Slide Deck: 6-Figure Jobs in Cannabis
Business Insider has rounded up the six-top earning positions in the cultivation, extraction, manufacturing, and retail sectors of cannabis.
Get all the healthcare coverage you need with the Digital Health Briefing from Insider Intelligence
The Digital Health Briefing is a curated, subscriber-only daily email newsletter from Insider Intelligence with insight into the future of healthcare.
DIGITAL HEALTH STARTUPS TO WATCH: An inside look at the top US startups transforming healthcare through AI, telehealth, and medical devices
Insider Intelligence examines the top five US startups in the areas of digital health with the most number of deals in the first half of 2020.
How a telehealth startup pivoted during the COVID-19 crisis, leading to 6x as many clients
Spanish startup HumanITCare went from 3 clients to 20 during the coronavirus health crisis and expects to end 2021 with a turnover of $1.2 million.
The CEO of major health insurer Humana laid out why he's betting big on primary care
Humana's investments in primary-care clinics are part of its strategy to integrate insurance and care delivery to provide better care to seniors.
People who've had COVID-19 might only need one vaccine jab — and saving shots on them could free up millions of doses for others
Some experts advocate waiving second vaccine shots for those who have had COVID-19 — but others think the approach is too risky.
Merck will reportedly help produce Johnson & Johnson COVID-19 vaccine shots after failing to make its own
The Washington Post reported that President Joe Biden would announce the partnership between the two US pharmaceutical giants.
Meet the top 8 VC firms that placed the most bets on startups changing how doctors get paid and building the future of medicine
Startups looking at new ways to pay for and provide care like Cityblock Health and VillageMD collectively raised $3.6 billion in 2020.
COVID Vaccine Tracker: J&J's shot joins Moderna and Pfizer, AstraZeneca and Novavax up next
The world will need multiple effective coronavirus vaccines to combat this pandemic. Here's the latest news on the frontrunners.
BridgeBio ran out of money 3 times on its way to getting its first drug approved. Now, the $11 billion biotech is facing its biggest test yet.
BridgeBio just received FDA approval for its first drug for an ultra-rare disease. It's the first proof-point for a company that drew skepticism.
The one big question surrounding Oscar Health ahead of its IPO
These are Insider's biggest healthcare stories for March 2.
The coronavirus variant first found in New York has spread to 14 other states, and the CDC has recorded more than 700 cases
Gregory Armstrong, of the CDC, told Bloomberg 585 cases of the variant first found in New York have emerged in the US in the past two weeks.
Novavax's COVID-19 vaccine could be authorized as early as May, its CEO said. A trial suggests it is 89% effective, though slightly less so against contagious variants.
CEO Stanley Erck said Novavax's COVID-19 vaccine could be authorized in the UK first before the FDA gives it emergency-use authorization.
HEALTH TECH'S ROLE IN THE NEW OFFICE NORMAL: How digital health firms are helping US employers facilitate return-to-work programs amid the coronavirus pandemic
Here's how tech giants and digital health companies are using their tech and clinical expertise to help US businesses with their reopening plans.
Why Johnson & Johnson's COVID-19 vaccine is probably the best shot
Some people might prefer Johnson & Johnson's shot because it was tested on variants, has milder side effects, and is easier to get.
All the differences between COVID-19 vaccines, summarized in a simple table that you can take to your vaccination appointment
This table shows the differences among the COVID-19 vaccines from Pfizer-BioNTech, Moderna, Johnson & Johnson, and AstraZeneca-Oxford University.
How companies like Walmart and Best Buy have curtailed their ambitions to upend the $3.8 trillion healthcare industry
Retailers like Walmart changed their approaches to take on the healthcare industry after the pandemic hit. Here's an update on their plans.
3 reasons to be optimistic about this summer, according to 18 doctors and scientists
Eighteen doctors and scientists share their predictions and plans for this summer, from sleepaway camp to national-park trips.
Singles get more 'likes' on dating apps if they've received a COVID-19 vaccine
Relationships expert Dr. Lamarche said that it could motivate younger groups on dating apps who might feel disincentivized to get a COVID-19 vaccine.
Digital Therapeutics Report: Latest DTx market trends and companies in growing digital health sector
Insider Intelligence explores the drivers lighting a fire under the DTx market and unpacks the ways vendors reach their intended audiences.
The FDA has authorized a 3rd coronavirus vaccine
These are Insider's biggest healthcare stories for March 1.
9 key questions answered about the worrying coronavirus variants spreading around the world, including whether vaccines block them, how contagious they are, and when they reached the US
Experts are investigating COVID-19 variants first found in the UK, South Africa, and Brazil, including whether vaccines work on them. Here's what we know.
Children under 12 will 'very likely' be able to get a vaccine in early 2022, Fauci said
COVID-19 vaccines will likely be available for high-school children in the fall, and for elementary-school children in early 2022, Dr. Anthony Fauci said.
The UK is rushing to track down a person infected with P.1, the coronavirus variant first found in Brazil. Officials don't know who the person is, or where in the country they are.
One of the people identified as having P.1, the variant first found in Brazil, didn't complete a registration form, so officials don't know who it is.
The Positives and Negatives of COVID-19's Impact on Healthcare
Insider Intelligence examines some of the major effects of the pandemic's spread on healthcare costs, as well as vaccine progress.
AI IN HEALTHCARE ADMINISTRATION: How digital health firms and big tech are using AI to ease doctors' administrative burden
Insider Intelligence explores factors driving burnout among clinicians, and how digital health firms and big tech are developing AI solutions.
Get all the healthcare coverage you need with the Digital Health Briefing from Insider Intelligence
The Digital Health Briefing is a curated, subscriber-only daily email newsletter from Insider Intelligence with insight into the future of healthcare.
Are novelists already writing about the Covid era? An author investigates
The novelist Julia Dahl reaches out to fellow writers like Kate Reed Petty, Jodi Picoult, and S.A. Cosby to ask how they are handling the coronavirus.